Ion channel targets - select biosciences' fourth annual conference.
Select Biosciences' Fourth Annual Ion Channel Targets conference brought together scientists from industry and academia who are interested in the discovery of therapeutics targeted to various ion channels implicated in human disease. Topics addressed included methodological aspects of screening for ion channel drugs, the discovery of novel inhibitors and activators of ion channels that are drug candidates, and suggestions of potential new ion channel targets.
Holmqvist
Mats
M
Novartis Institute for Biomedical Research, 250 Mass Avenue, Cambridge, MA 02139, USA. mats.holmqvist@novartis.com
Maduke
Merritt
M
D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy; D002219:Carbamates / Q000494:pharmacology / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects; D007473:Ion Channels / Q000187:drug effects / Q000502:physiology*; D010655:Phenylenediamines / Q000494:pharmacology / Q000627:therapeutic use
D000927:Anticonvulsants; D002219:Carbamates; D007473:Ion Channels; D010655:Phenylenediamines; C101866:ezogabine